Health

Results: 4465-4476 of 8220

GlobeNewswire associated0

Tiziana Life Sciences Announces Positive Results from Ozempic and Nasal Anti-CD3 Combination Study

SciBase initiates sales collaboration in Italy

A Race Against Blindness Grants $1 Million Supporting Axovia Therapeutics’ Planned Clinical Trial for Bardet-Biedl Syndrome (BBS)

PR Newswire associated0

Blue Earth Therapeutics Ltd announces completion of $76.5M Series A financing to accelerate development of next generation targeted radioligand therapies

TXN Systems Raises SEK 25 Million Series A to Advance First-in-Class Antibiotic

PR Newswire associated0

Telix Partners with Subtle Medical on AI-Enabled SubtlePET™ Software for Faster PET Imaging with Illuccix®

GlobeNewswire associated0

EAACI Unveils Groundbreaking Guidelines for IgE-Mediated Food Allergy Management

Leqembi® revenue totaled JPY 10 billion in the third quarter 2024

OKYO Pharma to Present at International Tear Film and Ocular Surface Society Conference

Business Wire logo

LivaNova Reports Third-Quarter 2024 Results

Business Wire logo

US FDA Accepts Biologics License Application (BLA) for HLX14, Biosimilar Candidate of PROLIA/XGEVA (denosumab)

Opening of Biosynth Biological Technology; a new Cutting-Edge Facility at Lifebay in Suzhou, China